UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K +31 (0) 35 206 2971 (Registrant's Telephone Number, Including Area Code) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2026 NewAmsterdam Pharma Company N.V. (Exact name of Registrant as Specified in Its Charter) The Netherlands 001-41562 N/A (State or Other Jurisdiction of Incorporation) Goomieer 2-35 Naarden The Netherlands 141 ...